{ "instance": { "mpw-10q_20200630.htm": { "axisCustom": 0, "axisStandard": 27, "contextCount": 267, "dts": { "calculationLink": { "local": [ "mpw-20200630_cal.xml" ] }, "definitionLink": { "local": [ "mpw-20200630_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "mpw-10q_20200630.htm" ] }, "labelLink": { "local": [ "mpw-20200630_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-doc-2019-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "mpw-20200630_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-ref-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "mpw-20200630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 469, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2019-01-31": 15, "http://xbrl.sec.gov/dei/2019-01-31": 12, "total": 27 }, "keyCustom": 59, "keyStandard": 259, "memberCustom": 63, "memberStandard": 33, "nsprefix": "mpw", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100100 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RealEstateDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100110 - Disclosure - Real Estate and Lending Activities", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivities", "shortName": "Real Estate and Lending Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RealEstateDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100120 - Disclosure - Debt", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PartnersCapitalNotesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100130 - Disclosure - Common Stock/Partner's Capital", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnerSCapital", "shortName": "Common Stock/Partner's Capital", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PartnersCapitalNotesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100140 - Disclosure - Stock Awards", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureStockAwards", "shortName": "Stock Awards", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100150 - Disclosure - Fair Value of Financial Instruments", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstruments", "shortName": "Fair Value of Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100160 - Disclosure - Earnings Per Share", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100170 - Disclosure - Commitments and Contingencies", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100180 - Disclosure - Subsequent Events", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100190 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "first": true, "lang": null, "name": "mpw:LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "first": true, "lang": null, "name": "mpw:LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:RealEstateDisclosureTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100200 - Disclosure - Real Estate and Lending Activities (Tables)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesTables", "shortName": "Real Estate and Lending Activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RealEstateDisclosureTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100210 - Disclosure - Debt (Tables)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100220 - Disclosure - Fair Value of Financial Instruments (Tables)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables", "shortName": "Fair Value of Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100230 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "INF", "first": true, "lang": null, "name": "mpw:NumberOfFacilities", "reportCount": 1, "unique": true, "unitRef": "U_mpwFacility", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100240 - Disclosure - Organization - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureOrganizationAdditionalInformationDetail", "shortName": "Organization - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "INF", "first": true, "lang": null, "name": "mpw:NumberOfFacilities", "reportCount": 1, "unique": true, "unitRef": "U_mpwFacility", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201613Member_20200101", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LoansAndLeasesReceivableAllowance", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100250 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201613Member_20200101", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LoansAndLeasesReceivableAllowance", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:RealEstateDisclosureTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100260 - Disclosure - Real Estate and Lending Activities - Net Assets Acquired (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail", "shortName": "Real Estate and Lending Activities - Net Assets Acquired (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:RealEstateDisclosureTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:RealEstateDisclosureTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_us-gaapPropertyPlantAndEquipmentByTypeAxis_mpwIntangibleLeaseAssetsMember_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100270 - Disclosure - Real Estate and Lending Activities - Net Assets Acquired (Parenthetical) (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredParentheticalDetail", "shortName": "Real Estate and Lending Activities - Net Assets Acquired (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:RealEstateDisclosureTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_us-gaapPropertyPlantAndEquipmentByTypeAxis_mpwIntangibleLeaseAssetsMember_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeaseRenewalTerm", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100280 - Disclosure - Real Estate Activities and Lending Activities - 2020 Activity - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "shortName": "Real Estate Activities and Lending Activities - 2020 Activity - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RealEstateDisclosureTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_mpwJointVenturePartnerMember_20200513", "decimals": "2", "lang": null, "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeaseRenewalTerm", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100290 - Disclosure - Real Estate Activities and Lending Activities - 2019 Activity - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "shortName": "Real Estate Activities and Lending Activities - 2019 Activity - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20190527", "decimals": null, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "mpw:ScheduleOfDevelopmentProjectsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "first": true, "lang": null, "name": "mpw:DevelopmentProjectsOriginalCommitmentAmount", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100300 - Disclosure - Real Estate and Lending Activities - Development Activities - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail", "shortName": "Real Estate and Lending Activities - Development Activities - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtMajorCustomersAxis_mpwErnestHealthIncMember_us-gaapRealEstatePropertiesAxis_mpwDevelopmentActivitiesMember_20200515", "decimals": "-5", "lang": null, "name": "mpw:DevelopmentProjectsOriginalCommitmentAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "mpw:ScheduleOfDevelopmentProjectsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "first": true, "lang": null, "name": "mpw:DevelopmentProjectsOriginalCommitmentAmount", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100310 - Disclosure - Real Estate and Lending Activities - Summary of Status on Current Development Projects (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "shortName": "Real Estate and Lending Activities - Summary of Status on Current Development Projects (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "mpw:ScheduleOfDevelopmentProjectsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": "INF", "first": true, "lang": null, "name": "mpw:NumberOfFacilitiesSold", "reportCount": 1, "unique": true, "unitRef": "U_mpwFacility", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100320 - Disclosure - Real Estate and Lending Activities - Disposals - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDisposalsAdditionalInformationDetail", "shortName": "Real Estate and Lending Activities - Disposals - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": "INF", "first": true, "lang": null, "name": "mpw:NumberOfFacilitiesSold", "reportCount": 1, "unique": true, "unitRef": "U_mpwFacility", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeaseRenewalTerm", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100330 - Disclosure - Real Estate and Lending Activities - Leasing Operations (Lessor) - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail", "shortName": "Real Estate and Lending Activities - Leasing Operations (Lessor) - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": "2", "lang": null, "name": "mpw:LeasesAnnualRentEscalationsPercentage", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DirectFinancingLeaseLeaseReceivable", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100340 - Disclosure - Real Estate and Lending Activities - Components of Total Investment in Financing Leases (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail", "shortName": "Real Estate and Lending Activities - Components of Total Investment in Financing Leases (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DirectFinancingLeaseLeaseReceivable", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_us-gaapUnusualRiskOrUncertaintyByNatureAxis_mpwCovidNineteenPandemicMember_20200630", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DeferredRevenueLeasesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100350 - Disclosure - Real Estate Activities and Lending Activities - Rent Deferrals - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivitiesRentDeferralsAdditionalInformationDetail", "shortName": "Real Estate Activities and Lending Activities - Rent Deferrals - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_us-gaapUnusualRiskOrUncertaintyByNatureAxis_mpwCovidNineteenPandemicMember_20200630", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DeferredRevenueLeasesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": "-3", "first": true, "lang": null, "name": "mpw:StraightLineRentAndOtherWriteOffNetOfTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100360 - Disclosure - Real Estate and Lending Activities - Adeptus Health Transition Properties - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail", "shortName": "Real Estate and Lending Activities - Adeptus Health Transition Properties - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtMajorCustomersAxis_mpwAdeptusHealthMember_20200101_20200630", "decimals": "INF", "lang": null, "name": "mpw:NumberOfFacilitiesSeverDeclineInOperatingResults", "reportCount": 1, "unique": true, "unitRef": "U_mpwFacility", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtMajorCustomersAxis_mpwAlectoHealthcareServicesMember_20200101_20200630", "decimals": "INF", "first": true, "lang": null, "name": "mpw:NumberOfLeasedProperties", "reportCount": 1, "unique": true, "unitRef": "U_mpwProperty", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100370 - Disclosure - Real Estate and Lending Activities - Alecto Facilities - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "shortName": "Real Estate and Lending Activities - Alecto Facilities - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtMajorCustomersAxis_mpwAlectoHealthcareServicesMember_20200101_20200630", "decimals": "INF", "first": true, "lang": null, "name": "mpw:NumberOfLeasedProperties", "reportCount": 1, "unique": true, "unitRef": "U_mpwProperty", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "mpw:ScheduleOfLoansReceivableTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NotesReceivableGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100380 - Disclosure - Real Estate and Lending Activities - Summary of Loans (Net of Allowance for Credit Loss) (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfLoansNetOfAllowanceForCreditLossDetail", "shortName": "Real Estate and Lending Activities - Summary of Loans (Net of Allowance for Credit Loss) (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "mpw:ScheduleOfLoansReceivableTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NotesReceivableGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "mpw:ScheduleOfLoansReceivableTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "first": true, "lang": null, "name": "mpw:AcquisitionLoans", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100390 - Disclosure - Real Estate and Lending Activities - Loans - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLoansAdditionalInformationDetail", "shortName": "Real Estate and Lending Activities - Loans - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtMajorCustomersAxis_mpwPrimotopHoldingsSARLMember_20200630", "decimals": "-6", "lang": null, "name": "us-gaap:DueFromJointVentures", "reportCount": 1, "unique": true, "unitRef": "U_iso4217EUR", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200401_20200630", "decimals": "-3", "first": true, "lang": null, "name": "mpw:RentBilled", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040 - Statement - Condensed Consolidated Statements of Net Income (Unaudited)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited", "shortName": "Condensed Consolidated Statements of Net Income (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200401_20200630", "decimals": "-3", "first": true, "lang": null, "name": "mpw:RentBilled", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAssetsTotalMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20200101_20200630", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100400 - Disclosure - Real Estate and Lending Activities - Concentration of Credit Risks and Related Party Transactions - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "shortName": "Real Estate and Lending Activities - Concentration of Credit Risks and Related Party Transactions - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapAssetsTotalMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20200101_20200630", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100410 - Disclosure - Debt - Summary of Debt (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "shortName": "Debt - Summary of Debt (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "lang": null, "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_us-gaapDebtInstrumentAxis_mpwFourPointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember_20200630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100420 - Disclosure - Debt - Summary of Debt (Parenthetical) (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtParentheticalDetail", "shortName": "Debt - Summary of Debt (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_us-gaapDebtInstrumentAxis_mpwFourPointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember_20200630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100430 - Disclosure - Debt - Principal Payments Due for Debt (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtPrincipalPaymentsDueForDebtDetail", "shortName": "Debt - Principal Payments Due for Debt (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtCounterpartyNameAxis_mpwBankOfAmericaNAMember_srtStatementGeographicalAxis_stprCA-BC_us-gaapDebtInstrumentAxis_mpwTermLoanMember_20200106", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217EUR", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100440 - Disclosure - Debt - British Pound Sterling Term Loan - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "shortName": "Debt - British Pound Sterling Term Loan - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtCounterpartyNameAxis_mpwBankOfAmericaNAMember_srtStatementGeographicalAxis_stprCA-BC_us-gaapDebtInstrumentAxis_mpwTermLoanMember_20200106", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217EUR", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtCounterpartyNameAxis_mpwBankOfAmericaNAMember_srtStatementGeographicalAxis_countryAU_us-gaapDebtInstrumentAxis_mpwTermLoanMember_20200523", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217AUD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100450 - Disclosure - Debt - Australian Term Loan Facility - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "shortName": "Debt - Australian Term Loan Facility - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtCounterpartyNameAxis_mpwBankOfAmericaNAMember_srtStatementGeographicalAxis_countryAU_us-gaapDebtInstrumentAxis_mpwTermLoanMember_20200523", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217AUD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": "INF", "first": true, "lang": null, "name": "mpw:PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100460 - Disclosure - Debt - Covenants - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtCovenantsAdditionalInformationDetail", "shortName": "Debt - Covenants - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": "INF", "first": true, "lang": null, "name": "mpw:PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfCommonStock", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100470 - Disclosure - Common Stock/Partners' Capital - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "shortName": "Common Stock/Partners' Capital - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:PartnersCapitalNotesDisclosureTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtConsolidatedEntitiesAxis_mpwMptOperatingPartnershipLPMember_20200101_20200630", "decimals": "-5", "lang": null, "name": "us-gaap:PartnersCapitalAccountUnitsSaleOfUnits", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100480 - Disclosure - Stock Awards - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureStockAwardsAdditionalInformationDetail", "shortName": "Stock Awards - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_us-gaapAwardTypeAxis_mpwEquityIncentivePlanMember_20200630", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "first": true, "lang": null, "name": "mpw:InterestAndRentReceivable", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100490 - Disclosure - Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail", "shortName": "Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200630", "decimals": "-3", "lang": null, "name": "mpw:Loans", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200401_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200401_20200630", "decimals": "-3", "lang": null, "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMortgagesMember_20200630", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100500 - Disclosure - Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Parenthetical) (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "shortName": "Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMortgagesMember_20200630", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200401_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100510 - Disclosure - Earnings Per Share - Calculation of Earnings Per Share (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail", "shortName": "Earnings Per Share - Calculation of Earnings Per Share (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200401_20200630", "decimals": "-3", "lang": null, "name": "mpw:UndistributedEarningAllocatedToParticipatingSecurities", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtStatementGeographicalAxis_mpwLynwoodCaliforniaMember_us-gaapBusinessAcquisitionAxis_mpwStFrancisMedicalCenterMember_20200101_20200630", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100520 - Disclosure - Commitments and Contingencies - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "shortName": "Commitments and Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtStatementGeographicalAxis_mpwLynwoodCaliforniaMember_us-gaapBusinessAcquisitionAxis_mpwStFrancisMedicalCenterMember_20200101_20200630", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtStatementGeographicalAxis_stprTX_us-gaapPropertyPlantAndEquipmentByTypeAxis_mpwMethodistHealthcareMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20200723_20200724", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfBusinessesAcquired", "reportCount": 1, "unique": true, "unitRef": "U_mpwHospital", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100530 - Disclosure - Subsequent Events - Additional Information (Detail)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail", "shortName": "Subsequent Events - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtStatementGeographicalAxis_stprTX_us-gaapPropertyPlantAndEquipmentByTypeAxis_mpwMethodistHealthcareMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20200723_20200724", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfBusinessesAcquired", "reportCount": 1, "unique": true, "unitRef": "U_mpwHospital", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20181231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100060 - Statement - Condensed Consolidated Statements of Equity / Capital", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital", "shortName": "Condensed Consolidated Statements of Equity / Capital", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtConsolidatedEntitiesAxis_mpwMptOperatingPartnershipLPMember_us-gaapPartnerTypeOfPartnersCapitalAccountAxis_us-gaapGeneralPartnerMember_20190101_20190331", "decimals": "-3", "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200401_20200630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100070 - Statement - Condensed Consolidated Statements of Equity / Capital (Parenthetical)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "shortName": "Condensed Consolidated Statements of Equity / Capital (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockDividendsPerShareDeclared", "us-gaap:CommonStockDividendsPerShareDeclared", "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_srtConsolidatedEntitiesAxis_mpwMptOperatingPartnershipLPMember_20200101_20200331", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockDividendsPerShareDeclared", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100080 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100090 - Disclosure - Organization", "role": "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureOrganization", "shortName": "Organization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "mpw-10q_20200630.htm", "contextRef": "C_0001287865_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 97, "tag": { "country_AU": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "AUSTRALIA", "terseLabel": "Australia [Member]" } } }, "localname": "AU", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "country_CH": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "SWITZERLAND", "terseLabel": "Switzerland [Member]" } } }, "localname": "CH", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "country_DE": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "GERMANY", "terseLabel": "Germany [Member]" } } }, "localname": "DE", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "country_GB": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED KINGDOM", "terseLabel": "United Kingdom [Member]", "verboseLabel": "British Pound Sterling [Member]" } } }, "localname": "GB", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES", "terseLabel": "U.S. [Member]" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r302" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r303" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line2", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r304" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r304" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r304" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r306" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r304" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r304" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r304" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r304" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r300" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r301" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "mpw_AcquisitionLoanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Acquisition loan.", "label": "Acquisition Loan [Member]", "terseLabel": "Acquisition Loan [Member]" } } }, "localname": "AcquisitionLoanMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_AcquisitionLoans": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfLoansNetOfAllowanceForCreditLossDetail": { "order": 10020.0, "parentTag": "us-gaap_NotesReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Acquisition loans.", "label": "Acquisition Loans", "terseLabel": "Acquisition loans", "verboseLabel": "Acquisition loan" } } }, "localname": "AcquisitionLoans", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLoansAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfLoansNetOfAllowanceForCreditLossDetail" ], "xbrltype": "monetaryItemType" }, "mpw_AcquisitionLoansAndOtherLoans": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10210.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Acquisition loans and other loans.", "label": "Acquisition Loans And Other Loans", "terseLabel": "Other loans" } } }, "localname": "AcquisitionLoansAndOtherLoans", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_AcuteCareCampusMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Acute care campus.", "label": "Acute Care Campus [Member]", "terseLabel": "Acute Care Campus [Member]" } } }, "localname": "AcuteCareCampusMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_AcuteCareHospitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Acute care hospital.", "label": "Acute Care Hospital [Member]", "terseLabel": "Acute Care Hospital [Member]" } } }, "localname": "AcuteCareHospitalMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_AdditionalPropertiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Additional properties.", "label": "Additional Properties [Member]", "terseLabel": "Additional Properties [Member]" } } }, "localname": "AdditionalPropertiesMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_AdeptusHealthMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Adeptus health.", "label": "Adeptus Health [Member]", "terseLabel": "Adeptus Health [Member]" } } }, "localname": "AdeptusHealthMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_AevisVictoriaSAMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Aevis Victoria SA.", "label": "Aevis Victoria S A [Member]", "terseLabel": "Aevis Victoria SA [Member]" } } }, "localname": "AevisVictoriaSAMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_AlectoHealthcareServicesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Alecto healthcare services.", "label": "Alecto Healthcare Services [Member]", "terseLabel": "Alecto Healthcare Services [Member]" } } }, "localname": "AlectoHealthcareServicesMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_BMIHealthcareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "BMI healthcare.", "label": "B M I Healthcare [Member]", "terseLabel": "BMI [Member]" } } }, "localname": "BMIHealthcareMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_BakersfieldCaliforniaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Bakersfield California.", "label": "Bakersfield California [Member]", "terseLabel": "Bakersfield, California [Member]" } } }, "localname": "BakersfieldCaliforniaMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "domainItemType" }, "mpw_BankOfAmericaNAMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Bank of America, N.A.", "label": "Bank Of America N A [Member]", "terseLabel": "Bank of America, N.A" } } }, "localname": "BankOfAmericaNAMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_BirminghamUkMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Birmingham UK", "label": "Birmingham Uk [Member]", "terseLabel": "Birmingham, England [Member]" } } }, "localname": "BirminghamUkMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_CircleHealthMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Circle Health Group.", "label": "Circle Health [Member]", "terseLabel": "Circle [Member]" } } }, "localname": "CircleHealthMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_CommitmentAndContingenciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commitment And Contingencies [Line Items]", "label": "Commitment And Contingencies [Line Items]", "terseLabel": "Commitment And Contingencies [Line Items]" } } }, "localname": "CommitmentAndContingenciesLineItems", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_CommitmentAndContingenciesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commitment And Contingencies [Table]", "label": "Commitment And Contingencies [Table]", "terseLabel": "Commitment And Contingencies [Table]" } } }, "localname": "CommitmentAndContingenciesTable", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_CommonUnitsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Common units.", "label": "Common Units [Member]", "terseLabel": "Common Units [Member]" } } }, "localname": "CommonUnitsMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "mpw_CommunityHospitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Community hospital.", "label": "Community Hospital [Member]", "terseLabel": "Community Hospital [Member]" } } }, "localname": "CommunityHospitalMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_CostMethodInvestmentOwnershipPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cost method investment ownership percentage.", "label": "Cost Method Investment Ownership Percentage", "terseLabel": "Ownership interest in joint venture under the cost method" } } }, "localname": "CostMethodInvestmentOwnershipPercentage", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_CostsOfLeasedAndRentedPropertyOrEquipment": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10150.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Costs of leased and rented property or equipment.", "label": "Costs Of Leased And Rented Property Or Equipment", "terseLabel": "Property-related" } } }, "localname": "CostsOfLeasedAndRentedPropertyOrEquipment", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "mpw_CovidNineteenPandemicMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Covid nineteen pandemic.", "label": "Covid Nineteen Pandemic [Member]", "terseLabel": "COVID-19 Pandemic [Member]" } } }, "localname": "CovidNineteenPandemicMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivitiesRentDeferralsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_CreditRatingMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Credit rating.", "label": "Credit Rating [Member]", "terseLabel": "Credit Rating" } } }, "localname": "CreditRatingMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_DahlenGermanyDEMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Dahlen, Germany.", "label": "Dahlen Germany D E [Member]", "terseLabel": "Dahlen, Germany [Member]" } } }, "localname": "DahlenGermanyDEMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_DarlingtonUnitedKingdomMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Darlington, United Kingdom.", "label": "Darlington United Kingdom [Member]", "terseLabel": "Darlington, United Kingdom [Memeber]" } } }, "localname": "DarlingtonUnitedKingdomMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_DavisAndJordanValleyFacilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Davis and Jordan valley facilities.", "label": "Davis And Jordan Valley Facilities [Member]", "terseLabel": "Davis and Jordan Valley Facilities [Member]" } } }, "localname": "DavisAndJordanValleyFacilitiesMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_DebtInstrumentEffectiveDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt instrument effective date.", "label": "Debt Instrument Effective Date", "terseLabel": "Debt instrument effective date" } } }, "localname": "DebtInstrumentEffectiveDate", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "mpw_DebtInstrumentInterestRateAdjustableBasedOnPricingGridPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt instrument interest rate adjustable based on pricing grid percentage.", "label": "Debt Instrument Interest Rate Adjustable Based On Pricing Grid Percentage", "terseLabel": "Applicable margin adjustable based on pricing grid, percentage" } } }, "localname": "DebtInstrumentInterestRateAdjustableBasedOnPricingGridPercentage", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_DebtInstrumentVariableInterestRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument variable interest rate.", "label": "Debt Instrument Variable Interest Rate", "terseLabel": "Variable interest rate" } } }, "localname": "DebtInstrumentVariableInterestRate", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_DevelopmentActivitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Development activities.", "label": "Development Activities [Member]", "terseLabel": "Development Activities [Member]" } } }, "localname": "DevelopmentActivitiesMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_DevelopmentProjectsEstimatedRentCommencementDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Development projects estimated rent commencement date.", "label": "Development Projects Estimated Rent Commencement Date", "terseLabel": "Estimated Rent Commencement Date" } } }, "localname": "DevelopmentProjectsEstimatedRentCommencementDate", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "stringItemType" }, "mpw_DevelopmentProjectsOriginalCommitmentAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Development projects original commitment amount.", "label": "Development Projects Original Commitment Amount", "terseLabel": "Commitment", "verboseLabel": "Commence rent in fourth quarter of 2021" } } }, "localname": "DevelopmentProjectsOriginalCommitmentAmount", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "order": 10050.0, "parentTag": "us-gaap_DirectFinancingLeaseNetInvestmentInLease", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Direct financing lease, unearned income and allowance for credit loss.", "label": "Direct Financing Lease Unearned Income And Allowance For Credit Loss", "negatedLabel": "Less: Unearned income and allowance for credit loss" } } }, "localname": "DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "mpw_EmployeeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Employee", "label": "Employee [Member]", "terseLabel": "Employee [Member]" } } }, "localname": "EmployeeMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_EquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity incentive plan member.", "label": "Equity Incentive Plan [Member]", "terseLabel": "Equity Incentive Plan [Member]" } } }, "localname": "EquityIncentivePlanMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_EquityInvestmentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity investments.", "label": "Equity Investments [Member]", "terseLabel": "Equity Investments [Member]" } } }, "localname": "EquityInvestmentsMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "mpw_ErnestHealthIncMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Ernest Health, Inc.", "label": "Ernest Health Inc [Member]", "terseLabel": "Ernest [Member]" } } }, "localname": "ErnestHealthIncMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "domainItemType" }, "mpw_FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial instruments measured at fair value on recurring basis.", "label": "Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]", "terseLabel": "Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]" } } }, "localname": "FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisLineItems", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "stringItemType" }, "mpw_FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial Instruments Measured At Fair Value On Recurring Basis [Table]", "label": "Financial Instruments Measured At Fair Value On Recurring Basis [Table]", "terseLabel": "Financial Instruments Measured At Fair Value On Recurring Basis [Table]" } } }, "localname": "FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisTable", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "stringItemType" }, "mpw_FivePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyFourMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Five point five zero zero percentage senior unsecured notes due two thousand twenty four.", "label": "Five Point Five Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Four [Member]", "terseLabel": "5.500% Senior Unsecured Notes Due 2024 [Member]" } } }, "localname": "FivePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyFourMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_FivePointTwoFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Five point two five zero percentage senior unsecured notes due two thousand twenty six.", "label": "Five Point Two Five Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Six [Member]", "terseLabel": "5.250% Senior Unsecured Notes Due 2026 [Member]" } } }, "localname": "FivePointTwoFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_FivePointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySevenMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Five point zero zero zero percentage senior unsecured notes due two thousand twenty seven.", "label": "Five Point Zero Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Seven [Member]", "terseLabel": "5.000% Senior Unsecured Notes Due 2027 [Member]" } } }, "localname": "FivePointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySevenMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_FourPointSixTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyNineMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Four point six two five percentage senior unsecured notes due two thousand twenty nine.", "label": "Four Point Six Two Five Percentage Senior Unsecured Notes Due Two Thousand Twenty Nine [Member]", "terseLabel": "4.625% Senior Unsecured Notes Due 2029 [Member]" } } }, "localname": "FourPointSixTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyNineMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_FourPointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Four point zero zero zero percentage senior unsecured notes due two thousand twenty two.", "label": "Four Point Zero Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Two [Member]", "terseLabel": "4.000% Senior Unsecured Notes due 2022 [Member]" } } }, "localname": "FourPointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyTwoMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_GeneralAcuteCareHospitalAndHealthcareSystemMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "General Acute Care Hospital And Healthcare System [Member]", "label": "General Acute Care Hospital And Healthcare System [Member]", "terseLabel": "General Acute Care Hospital and Healthcare System [Member]" } } }, "localname": "GeneralAcuteCareHospitalAndHealthcareSystemMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_GrossInvestmentInRealEstateAssets": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10230.0, "parentTag": "mpw_NetInvestmentInRealEstateAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Gross investment in real estate assets", "label": "Gross Investment In Real Estate Assets", "totalLabel": "Gross investment in real estate assets" } } }, "localname": "GrossInvestmentInRealEstateAssets", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_HealthscopeLimitedMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Healthscope Limited.", "label": "Healthscope Limited [Member]", "terseLabel": "Healthscope Limited [Member]" } } }, "localname": "HealthscopeLimitedMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_HospitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Hospital.", "label": "Hospital [Member]", "terseLabel": "Hospital [Member]" } } }, "localname": "HospitalMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_HoustonTexasMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Houston, Texas.", "label": "Houston Texas [Member]", "terseLabel": "Houston, Texas [Member]" } } }, "localname": "HoustonTexasMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "domainItemType" }, "mpw_IncreaseDecreaseInInterestAndRentReceivable": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10270.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Increase decrease in interest and rent receivable.", "label": "Increase Decrease In Interest And Rent Receivable", "negatedLabel": "Interest and rent receivables" } } }, "localname": "IncreaseDecreaseInInterestAndRentReceivable", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "mpw_InpatientRehabilitationHospitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Inpatient Rehabilitation Hospital [Member]", "label": "Inpatient Rehabilitation Hospital [Member]", "terseLabel": "Inpatient Rehabilitation Hospital [Member]" } } }, "localname": "InpatientRehabilitationHospitalMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_IntangibleLeaseAssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Intangible Lease Assets", "label": "Intangible Lease Assets [Member]", "terseLabel": "Intangible Lease Assets - Subject to Amortization [Member]" } } }, "localname": "IntangibleLeaseAssetsMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_InterestAndRentReceivable": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10180.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Interest and rent receivable.", "label": "Interest And Rent Receivable", "terseLabel": "Interest and rent receivables", "verboseLabel": "Interest and rent receivables, Book value" } } }, "localname": "InterestAndRentReceivable", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_JointVenturePartnerMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Joint Venture Partner [Member]", "label": "Joint Venture Partner [Member]", "terseLabel": "Joint Venture Partner [Member]" } } }, "localname": "JointVenturePartnerMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLoansAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_LTIPUnitsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "LTIP Units.", "label": "L T I P Units [Member]", "terseLabel": "LTIP Units [Member]" } } }, "localname": "LTIPUnitsMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "domainItemType" }, "mpw_LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10250.0, "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Land buildings and improvements intangible lease assets and other.", "label": "Land Buildings And Improvements Intangible Lease Assets And Other", "terseLabel": "Land, buildings and improvements, intangible lease assets, and other" } } }, "localname": "LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_LeaseConcentrationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lease concentration.", "label": "Lease Concentration [Member]", "terseLabel": "Lease Concentration [Member]" } } }, "localname": "LeaseConcentrationMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_LeaseFixedMinimumAnnualEscalationsPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lease fixed minimum annual escalations percentage.", "label": "Lease Fixed Minimum Annual Escalations Percentage", "terseLabel": "Fixed minimum annual escalations" } } }, "localname": "LeaseFixedMinimumAnnualEscalationsPercentage", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_LeasesAnnualRentEscalationsPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Leases annual rent escalations percentage.", "label": "Leases Annual Rent Escalations Percentage", "terseLabel": "Annual rent escalations" } } }, "localname": "LeasesAnnualRentEscalationsPercentage", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_LeasesFixedEscalationPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Leases fixed escalation period.", "label": "Leases Fixed Escalation Period", "terseLabel": "Leases fixed escalations" } } }, "localname": "LeasesFixedEscalationPeriod", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "mpw_LessorOperatingLeaseInitialFixedTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lessor operating lease initial fixed term.", "label": "Lessor Operating Lease Initial Fixed Term", "terseLabel": "Initial fixed term of lease" } } }, "localname": "LessorOperatingLeaseInitialFixedTerm", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "gYearItemType" }, "mpw_Loans": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Loans.", "label": "Loans", "terseLabel": "Loans, Book value" } } }, "localname": "Loans", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "xbrltype": "monetaryItemType" }, "mpw_LoansLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loans.", "label": "Loans [Line Items]", "terseLabel": "Loans [Line Items]" } } }, "localname": "LoansLineItems", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLoansAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_LoansTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Loans [Table]", "label": "Loans [Table]", "terseLabel": "Loans [Table]" } } }, "localname": "LoansTable", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLoansAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "mpw_LongTermAcuteCareHospitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Long-term acute care hospital.", "label": "Long Term Acute Care Hospital [Member]", "terseLabel": "Long-term Acute Care Hospital [Member]" } } }, "localname": "LongTermAcuteCareHospitalMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "order": 10060.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Long term debt maturities repayments of principal after year four.", "label": "Long Term Debt Maturities Repayments Of Principal After Year Four", "terseLabel": "Thereafter" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "xbrltype": "monetaryItemType" }, "mpw_LongTermIncentivePlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Long term incentive plan.", "label": "Long Term Incentive Plan [Member]", "terseLabel": "Long Term Incentive Plan [Member]" } } }, "localname": "LongTermIncentivePlanMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "mpw_LynwoodCaliforniaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lynwood, California.", "label": "Lynwood California [Member]", "terseLabel": "Lynwood, California [Member]" } } }, "localname": "LynwoodCaliforniaMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_MaximumPercentageOfEntitysAssetsInvestedOnSingleProperty": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Maximum percentage of entity's assets invested on single property.", "label": "Maximum Percentage Of Entitys Assets Invested On Single Property", "terseLabel": "Largest percentage of entity's assets invested on single property" } } }, "localname": "MaximumPercentageOfEntitysAssetsInvestedOnSingleProperty", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_MaximumPercentageOfUnencumberedAssets": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Maximum percentage of unencumbered assets.", "label": "Maximum Percentage Of Unencumbered Assets", "terseLabel": "Maximum percentage of total unencumbered assets" } } }, "localname": "MaximumPercentageOfUnencumberedAssets", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtCovenantsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_MethodistHealthcareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Methodist healthcare.", "label": "Methodist Healthcare [Member]", "terseLabel": "Methodist [Member]" } } }, "localname": "MethodistHealthcareMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_MptOperatingPartnershipLPMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "MPT Operating Partnership L.P", "label": "Mpt Operating Partnership L P [Member]", "terseLabel": "MPT Operating Partnership, L.P. [Member]" } } }, "localname": "MptOperatingPartnershipLPMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "domainItemType" }, "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Net income less participating securities share in earnings.", "label": "Net Income Less Participating Securities Share In Earnings", "totalLabel": "Net income, less participating securities\u2019 share in earnings" } } }, "localname": "NetIncomeLessParticipatingSecuritiesShareInEarnings", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail" ], "xbrltype": "monetaryItemType" }, "mpw_NetInvestmentInRealEstateAssets": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10160.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Net Investment In Real Estate Assets", "label": "Net Investment In Real Estate Assets", "totalLabel": "Net investment in real estate assets" } } }, "localname": "NetInvestmentInRealEstateAssets", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_NeuroPsychiatricHospitalsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "NeuroPsychiatric hospitals.", "label": "Neuro Psychiatric Hospitals [Member]", "terseLabel": "NeuroPsychiatric Hospitals [Member]" } } }, "localname": "NeuroPsychiatricHospitalsMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "domainItemType" }, "mpw_NumberOfDirectFinancingLeases": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of direct financing leases.", "label": "Number Of Direct Financing Leases", "terseLabel": "Number of direct financing leases" } } }, "localname": "NumberOfDirectFinancingLeases", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfFacilities": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of facilities.", "label": "Number Of Facilities", "terseLabel": "Number of facilities" } } }, "localname": "NumberOfFacilities", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureOrganizationAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfFacilitiesSeverDeclineInOperatingResults": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of facilities sever decline in operating results.", "label": "Number Of Facilities Sever Decline In Operating Results", "terseLabel": "Number of facilities sever decline in operating results" } } }, "localname": "NumberOfFacilitiesSeverDeclineInOperatingResults", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfFacilitiesSold": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of facilities sold.", "label": "Number Of Facilities Sold", "terseLabel": "Number of facilities sold" } } }, "localname": "NumberOfFacilitiesSold", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDisposalsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfFinancingLeases": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of financing leases.", "label": "Number Of Financing Leases", "terseLabel": "Number of financing leases" } } }, "localname": "NumberOfFinancingLeases", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfLeaseExtensionOptions": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of lease extension options.", "label": "Number Of Lease Extension Options", "terseLabel": "Number of lease extension options" } } }, "localname": "NumberOfLeaseExtensionOptions", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfLeasedProperties": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of leased properties.", "label": "Number Of Leased Properties", "terseLabel": "Number of leased properties" } } }, "localname": "NumberOfLeasedProperties", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfLessorProperties": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of lessor properties.", "label": "Number Of Lessor Properties", "terseLabel": "Number of properties" } } }, "localname": "NumberOfLessorProperties", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfPartnersSharedRemainingOwnershipInterest": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of partners shared remaining ownership interest.", "label": "Number Of Partners Shared Remaining Ownership Interest", "terseLabel": "Number of partners shared remaining ownership percentage" } } }, "localname": "NumberOfPartnersSharedRemainingOwnershipInterest", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfPropertiesSold": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of properties sold.", "label": "Number Of Properties Sold", "terseLabel": "Number of properties sold" } } }, "localname": "NumberOfPropertiesSold", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDisposalsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_NumberOfReLeasedProperties": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of re-leased properties.", "label": "Number Of Re Leased Properties", "terseLabel": "Number of Re-leased Properties" } } }, "localname": "NumberOfReLeasedProperties", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "mpw_ObligationsToTenantsAndOtherLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10140.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Obligations to tenants and other lease liabilities.", "label": "Obligations To Tenants And Other Lease Liabilities", "terseLabel": "Obligations to tenants and other lease liabilities" } } }, "localname": "ObligationsToTenantsAndOtherLeaseLiabilities", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_OperatingPartnershipMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Operating partnership.", "label": "Operating Partnership [Member]", "terseLabel": "Operating Partnership [Member]" } } }, "localname": "OperatingPartnershipMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_OtherAcquisitionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other acquisitions.", "label": "Other Acquisitions [Member]", "terseLabel": "Other Acquisitions [Member]" } } }, "localname": "OtherAcquisitionsMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 10040.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Other comprehensive income unrealized gain (loss) on derivatives net of tax.", "label": "Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax", "terseLabel": "Unrealized loss on interest rate swap", "verboseLabel": "Unrealized loss on interest rate swap, net of tax" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "mpw_OtherFinancingLeasesNetOfAllowanceForCreditLoss": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "order": 10020.0, "parentTag": "us-gaap_NetInvestmentInLease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Other financing leases, net of allowance for credit loss.", "label": "Other Financing Leases Net Of Allowance For Credit Loss", "terseLabel": "Other financing leases (net of allowance for credit loss)" } } }, "localname": "OtherFinancingLeasesNetOfAllowanceForCreditLoss", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "mpw_OtherLoans": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfLoansNetOfAllowanceForCreditLossDetail": { "order": 10030.0, "parentTag": "us-gaap_NotesReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Other loans", "label": "Other Loans", "terseLabel": "Other loans" } } }, "localname": "OtherLoans", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfLoansNetOfAllowanceForCreditLossDetail" ], "xbrltype": "monetaryItemType" }, "mpw_OtherLoansMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other Loans", "label": "Other Loans [Member]", "terseLabel": "Other Loans [Member]" } } }, "localname": "OtherLoansMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "mpw_PayableDueToParentCompany": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10150.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Payable due to parent company", "label": "Payable Due To Parent Company", "terseLabel": "Payable due to Medical Properties Trust, Inc." } } }, "localname": "PayableDueToParentCompany", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_PaymentForProceedsFromConstructionInProgressEquipmentAndOther": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10150.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Payment for (proceeds from) construction-in-progress, equipment and other.", "label": "Payment For Proceeds From Construction In Progress Equipment And Other", "negatedLabel": "Other investments, net" } } }, "localname": "PaymentForProceedsFromConstructionInProgressEquipmentAndOther", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "mpw_PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10070.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Payments for proceeds from lease deposits and other obligations to tenants.", "label": "Payments For Proceeds From Lease Deposits And Other Obligations To Tenants", "negatedLabel": "Lease deposits and other obligations to tenants" } } }, "localname": "PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "mpw_PercentageOfDeferredRevenueLease": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of deferred revenue lease.", "label": "Percentage Of Deferred Revenue Lease", "terseLabel": "Percentage of deferred revenue lease" } } }, "localname": "PercentageOfDeferredRevenueLease", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivitiesRentDeferralsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of dividends payable on basis of adjusted operating funds.", "label": "Percentage Of Dividends Payable On Basis Of Adjusted Operating Funds", "terseLabel": "Percentage of dividends which could be paid from adjusted operating funds" } } }, "localname": "PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtCovenantsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_PercentageOfDividendsPayableOnSeniorUnsecuredNotes": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of dividends payable on senior unsecured notes.", "label": "Percentage Of Dividends Payable On Senior Unsecured Notes", "terseLabel": "Percentage of dividends which could be paid from operation funds" } } }, "localname": "PercentageOfDividendsPayableOnSeniorUnsecuredNotes", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtCovenantsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_PercentageOfVacantOnLeasedProperty": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of vacant on leased property.", "label": "Percentage Of Vacant On Leased Property", "terseLabel": "Percentage of vacant on leased property" } } }, "localname": "PercentageOfVacantOnLeasedProperty", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "mpw_PooleUnitedKingdomMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Poole United Kingdom.", "label": "Poole United Kingdom [Member]", "terseLabel": "Poole, England [Member]" } } }, "localname": "PooleUnitedKingdomMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_PreAcquisitionRentCollectedCircleTransaction": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10250.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Pre acquisition rent collected circle transaction.", "label": "Pre Acquisition Rent Collected Circle Transaction", "negatedLabel": "Pre-acquisition rent collected - Circle Transaction" } } }, "localname": "PreAcquisitionRentCollectedCircleTransaction", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "mpw_PrimeFacilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Prime facilities.", "label": "Prime Facilities [Member]", "terseLabel": "Prime Facilities [Member]" } } }, "localname": "PrimeFacilitiesMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_PrimeHealthCareServicesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Prime Health Care Services.", "label": "Prime Health Care Services [Member]", "terseLabel": "Prime [Member]" } } }, "localname": "PrimeHealthCareServicesMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_PrimotopHoldingsSARLMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primotop holdings s.a.r.l.", "label": "Primotop Holdings S A R L [Member]", "terseLabel": "Primotop Holdings S.a.r.l. [Member]" } } }, "localname": "PrimotopHoldingsSARLMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLoansAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_ProspectAndCircleMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Prospect and Circle.", "label": "Prospect And Circle [Member]", "terseLabel": "Prospect and Circle [Member]" } } }, "localname": "ProspectAndCircleMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_ProspectMedicalHoldingsIncMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Prospect Medical Holdings Inc.", "label": "Prospect Medical Holdings Inc [Member]", "terseLabel": "Prospect [Member]" } } }, "localname": "ProspectMedicalHoldingsIncMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_RealEstateAccumulatedDepreciationAndAmortization": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10240.0, "parentTag": "mpw_NetInvestmentInRealEstateAssets", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Real estate accumulated depreciation and amortization.", "label": "Real Estate Accumulated Depreciation And Amortization", "negatedLabel": "Accumulated depreciation and amortization" } } }, "localname": "RealEstateAccumulatedDepreciationAndAmortization", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_RealEstateAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Real Estate Assets [Abstract]", "label": "Real Estate Assets [Abstract]", "terseLabel": "Real estate assets" } } }, "localname": "RealEstateAssetsAbstract", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "mpw_RehabilitationHospitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Rehabilitation hospital.", "label": "Rehabilitation Hospital [Member]", "terseLabel": "Rehabilitation Hospital with Covenant Health System [Member]" } } }, "localname": "RehabilitationHospitalMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_RentBilled": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10170.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Rent billed", "label": "Rent Billed", "terseLabel": "Rent billed" } } }, "localname": "RentBilled", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "mpw_SaintLukeSHealthSystemMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Saint Luke's Health System.", "label": "Saint Luke S Health System [Member]", "terseLabel": "Saint Luke's Health System [Member]" } } }, "localname": "SaintLukeSHealthSystemMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_ScheduleOfDevelopmentProjectsTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of development projects.", "label": "Schedule Of Development Projects Table [Text Block]", "terseLabel": "Summary of Status on Current Development Projects" } } }, "localname": "ScheduleOfDevelopmentProjectsTableTextBlock", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "mpw_ScheduleOfLoansReceivableTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of loans receivable.", "label": "Schedule Of Loans Receivable Table [Text Block]", "terseLabel": "Summary of Loans (Net of Allowance for Credit Loss)" } } }, "localname": "ScheduleOfLoansReceivableTableTextBlock", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "mpw_SixPointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFourMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Six point three seven five percentage senior unsecured notes due two thousand twenty four.", "label": "Six Point Three Seven Five Percentage Senior Unsecured Notes Due Two Thousand Twenty Four [Member]", "terseLabel": "6.375% Senior Unsecured Notes due 2024 [Member]" } } }, "localname": "SixPointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFourMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_StFrancisMedicalCenterMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "St. Francis Medical Center.", "label": "St Francis Medical Center [Member]", "terseLabel": "St. Francis Medical Center [Member]" } } }, "localname": "StFrancisMedicalCenterMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_StewardMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Steward.", "label": "Steward [Member]", "terseLabel": "Steward [Member]" } } }, "localname": "StewardMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_StockIssuedDuringPeriodSharesStockVestingAndAmortizationOfStockBasedCompensation": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock issued during period, shares, stock vesting and amortization of stock-based compensation.", "label": "Stock Issued During Period Shares Stock Vesting And Amortization Of Stock Based Compensation", "terseLabel": "Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockVestingAndAmortizationOfStockBasedCompensation", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "sharesItemType" }, "mpw_StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Stock issued during period value stock vesting and amortization of stock based compensation.", "label": "Stock Issued During Period Value Stock Vesting And Amortization Of Stock Based Compensation", "terseLabel": "Stock (Unit) vesting and amortization of stock (unit)-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "mpw_StraightLineRentAndOtherWriteOffNetOfTax": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10230.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Straight-line rent and other write-off net off tax.", "label": "Straight Line Rent And Other Write Off Net Of Tax", "terseLabel": "Straight-line rent and other write-off, net of tax" } } }, "localname": "StraightLineRentAndOtherWriteOffNetOfTax", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "mpw_StraightLineRentReceivable": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10190.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Straight-line rent receivable", "label": "Straight Line Rent Receivable", "terseLabel": "Straight-line rent receivables" } } }, "localname": "StraightLineRentReceivable", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "mpw_StraightLineRentRevenueAndOther": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10190.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Straight-line rent revenue and other.", "label": "Straight Line Rent Revenue And Other", "negatedLabel": "Straight-line rent revenue and other" } } }, "localname": "StraightLineRentRevenueAndOther", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "mpw_StraightLineRentRevenueNetOfWriteOffs": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10180.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Straight line rent revenue net of write offs.", "label": "Straight Line Rent Revenue Net Of Write Offs", "terseLabel": "Straight-line rent" } } }, "localname": "StraightLineRentRevenueNetOfWriteOffs", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "mpw_SupplementalScheduleOfNonCashFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Supplemental Schedule Of Non Cash Financing Activities [Abstract]", "label": "Supplemental Schedule Of Non Cash Financing Activities [Abstract]", "terseLabel": "Supplemental schedule of non-cash financing activities:" } } }, "localname": "SupplementalScheduleOfNonCashFinancingActivitiesAbstract", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "mpw_SwissHealthcareRealEstateCompanyInfracoreSAMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Swiss Healthcare Real Estate Company Infracore SA.", "label": "Swiss Healthcare Real Estate Company Infracore S A [Member]", "terseLabel": "Swiss Healthcare Real Estate Company Infracore S A [Member]" } } }, "localname": "SwissHealthcareRealEstateCompanyInfracoreSAMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "mpw_TermLoanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Term loan.", "label": "Term Loan [Member]", "terseLabel": "Term Loan [Member]" } } }, "localname": "TermLoanMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail" ], "xbrltype": "domainItemType" }, "mpw_ThreePointSixNineTwoPercentageSeniorUnsecuredNotesDueTwoThousandTwentyEightMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Three point six nine two percentage senior unsecured notes due two thousand twenty eight.", "label": "Three Point Six Nine Two Percentage Senior Unsecured Notes Due Two Thousand Twenty Eight [Member]", "terseLabel": "3.692% Senior Unsecured Notes due 2028 [Member]" } } }, "localname": "ThreePointSixNineTwoPercentageSeniorUnsecuredNotesDueTwoThousandTwentyEightMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_ThreePointThreeTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFiveMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Three point three two five percentage senior unsecured notes due two thousand twenty five.", "label": "Three Point Three Two Five Percentage Senior Unsecured Notes Due Two Thousand Twenty Five [Member]", "terseLabel": "3.325% Senior Unsecured Notes Due 2025 [Member]" } } }, "localname": "ThreePointThreeTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFiveMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_TwoPointFiveFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two point five five zero percentage senior unsecured notes due two thousand twenty three.", "label": "Two Point Five Five Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Three [Member]", "terseLabel": "2.550% Senior Unsecured Notes due 2023 [Member]" } } }, "localname": "TwoPointFiveFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyThreeMember", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "mpw_UndistributedEarningAllocatedToParticipatingSecurities": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail": { "order": 10050.0, "parentTag": "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Undistributed earning allocated to participating securities.", "label": "Undistributed Earning Allocated To Participating Securities", "negatedLabel": "Participating securities\u2019 share in earnings" } } }, "localname": "UndistributedEarningAllocatedToParticipatingSecurities", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail" ], "xbrltype": "monetaryItemType" }, "mpw_UnutilizedFinancingFees": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10240.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10110.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Unutilized financing fees.", "label": "Unutilized Financing Fees", "negatedLabel": "Unutilized financing fees", "terseLabel": "Unutilized financing costs" } } }, "localname": "UnutilizedFinancingFees", "nsuri": "http://www.medicalpropertiestrust.com/20200630", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r293", "r308" ], "lang": { "en-US": { "role": { "documentation": "Information by consolidated entity or group of entities.", "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity.", "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [ "r305" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.", "label": "Contractual Obligation Fiscal Year Maturity Schedule Table [Text Block]", "terseLabel": "Principal Payments Due on Debt" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtTables" ], "xbrltype": "textBlockItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r35", "r79", "r311" ], "lang": { "en-US": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of investment, including named security. Excludes consolidated entity.", "label": "Equity Method Investee Name [Domain]", "terseLabel": "Investment, Name" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLoansAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Continent of Europe.", "label": "Europe [Member]", "terseLabel": "Europe [Member]" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r118", "r162", "r165", "r279" ], "lang": { "en-US": { "role": { "documentation": "Information by name or description of a single external customer or a group of external customers.", "label": "Major Customers [Axis]", "terseLabel": "Customer" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLoansAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Single external customer or group of external customers.", "label": "Name Of Major Customer [Domain]", "terseLabel": "Customer" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLoansAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Axis]", "terseLabel": "Ownership" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Domain]", "terseLabel": "Ownership" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ProFormaMember": { "auth_ref": [ "r137", "r237" ], "lang": { "en-US": { "role": { "documentation": "Information reported based on historical fact adjusted for fully or partially assumed fact. Excludes information reported for future period (forecast).", "label": "Pro Forma [Member]", "terseLabel": "Pro Forma [Member]" } } }, "localname": "ProFormaMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Range [Axis]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Range [Member]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": { "auth_ref": [ "r294", "r310", "r312" ], "lang": { "en-US": { "role": { "documentation": "Information by name of property.", "label": "Real Estate And Accumulated Depreciation Description Of Property [Axis]", "terseLabel": "Name of Property" } } }, "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the property, for example, but not limited to, ABC Shopping Center.", "label": "Real Estate And Accumulated Depreciation Name Of Property [Domain]", "terseLabel": "Name of Property" } } }, "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Repurchase Agreement Counterparty Name [Domain]", "terseLabel": "Counterparty Name" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario Unspecified [Domain]", "terseLabel": "Scenario" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r127" ], "lang": { "en-US": { "role": { "documentation": "Information by name of investment, including named security. Excludes consolidated entity.", "label": "Schedule Of Equity Method Investment Equity Method Investee Name [Axis]", "terseLabel": "Investment, Name" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLoansAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Geographical area.", "label": "Segment Geographical [Domain]", "terseLabel": "Geographical" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r117", "r162", "r164", "r278", "r291", "r292", "r307", "r309" ], "lang": { "en-US": { "role": { "documentation": "Information by geographical components.", "label": "Statement Geographical [Axis]", "terseLabel": "Geographical" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r137", "r237" ], "lang": { "en-US": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Statement Scenario [Axis]", "terseLabel": "Scenario" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r119", "r234" ], "lang": { "en-US": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title Of Individual [Axis]", "terseLabel": "Title of Individual" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title Of Individual With Relationship To Entity [Domain]", "terseLabel": "Title of Individual" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "stpr_CA-BC": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "BRITISH COLUMBIA", "terseLabel": "British Pound Sterling [Member]" } } }, "localname": "CA-BC", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "stpr_KS": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "KANSAS", "terseLabel": "Kansas [Member]" } } }, "localname": "KS", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "stpr_TX": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "TEXAS", "terseLabel": "Texas [Member]" } } }, "localname": "TX", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "stpr_UT": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UTAH", "terseLabel": "Utah [Member]" } } }, "localname": "UT", "nsuri": "http://xbrl.sec.gov/stpr/2018-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201613Member": { "auth_ref": [ "r128" ], "lang": { "en-US": { "role": { "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.", "label": "Accounting Standards Update201613 [Member]", "terseLabel": "ASU 2016-13 [Member]" } } }, "localname": "AccountingStandardsUpdate201613Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r249", "r269" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10120.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.", "label": "Accounts Payable And Accrued Liabilities Current And Noncurrent", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r38", "r39", "r40" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10090.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 }, "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets2": { "order": 10040.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income Loss Net Of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r37", "r40", "r41", "r190" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income [Member]", "terseLabel": "Accumulated Other Comprehensive Loss [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r130" ], "lang": { "en-US": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite Lived Intangible Assets Weighted Average Useful Life", "terseLabel": "Weighted-average useful life of acquired intangible lease assets (in years)" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredParentheticalDetail" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r14" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10070.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid In Capital Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid In Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r86" ], "lang": { "en-US": { "role": { "documentation": "Information by new accounting pronouncement.", "label": "Adjustments For New Accounting Pronouncements [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r72", "r218" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10180.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization Of Financing Costs And Discounts", "terseLabel": "Amortization of deferred financing costs and debt discount" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r72", "r131" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10220.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10090.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "negatedLabel": "Real estate impairment charges", "terseLabel": "Impairment charges" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r113", "r242", "r259" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsTotalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date.", "label": "Assets Total [Member]", "terseLabel": "Total Gross Assets [Member]" } } }, "localname": "AssetsTotalMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r167", "r170" ], "lang": { "en-US": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r197", "r198" ], "lang": { "en-US": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r133" ], "lang": { "en-US": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Building [Member]" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r174", "r175" ], "lang": { "en-US": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.", "label": "Business Acquisition Cost Of Acquired Entity Transaction Costs", "terseLabel": "Stamp duties and registration fees" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivitiesRentDeferralsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredParentheticalDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r173" ], "lang": { "en-US": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition Percentage Of Voting Interests Acquired", "terseLabel": "Ownership interest" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r178", "r179", "r180" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination Consideration Transferred1", "terseLabel": "Purchase price of acquisition" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r177" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail": { "order": 10010.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets", "terseLabel": "Total assets acquired", "verboseLabel": "Acquisition loan" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r177" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail": { "order": 10020.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities", "negatedLabel": "Liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r176", "r177" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net", "totalLabel": "Total" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r20", "r74" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10170.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash And Cash Equivalents At Carrying Value", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]", "verboseLabel": "Cash, cash equivalents, and restricted cash are comprised of the following:" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r69", "r74", "r76" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r69", "r210" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect", "totalLabel": "Decrease in cash, cash equivalents, and restricted cash for period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class Of Stock [Line Items]", "terseLabel": "Class Of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments And Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r136", "r138" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments And Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r154" ], "lang": { "en-US": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock Dividends Per Share Declared", "terseLabel": "Dividends declared per common share (unit)", "verboseLabel": "Dividends (Distributions) declared per common share / unit" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Par Value [Member]", "verboseLabel": "Common Units [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock Par Or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r12", "r147" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock Shares Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r12" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10060.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock Value", "terseLabel": "Common stock, $0.001 par value. Authorized 750,000 shares; issued and outstanding \u2014 528,641 shares at June 30, 2020 and 517,522 shares at December 31, 2019" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonUnitIssued": { "auth_ref": [ "r101", "r102", "r154" ], "lang": { "en-US": { "role": { "documentation": "Number of common units issued of limited liability company (LLC).", "label": "Common Unit Issued", "terseLabel": "Limited Partners, units issued" } } }, "localname": "CommonUnitIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonUnitOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of common units of ownership outstanding of a limited liability company (LLC).", "label": "Common Unit Outstanding", "terseLabel": "Limited Partners, units outstanding" } } }, "localname": "CommonUnitOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r43", "r45", "r46" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax", "totalLabel": "Comprehensive income attributable to MPT common stockholders (Operating Partnership Partners)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r43", "r45", "r184", "r185", "r193" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 10020.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest", "negatedLabel": "Comprehensive income attributable to non-controlling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r43", "r45", "r183", "r193" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 10010.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest", "totalLabel": "Total comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r105", "r106", "r207", "r208" ], "lang": { "en-US": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r105", "r106", "r207", "r208", "r280" ], "lang": { "en-US": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk By Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r105", "r106", "r207", "r208", "r280" ], "lang": { "en-US": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk By Type [Axis]", "terseLabel": "Concentration Risk Type" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r105", "r106", "r207", "r208" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk Percentage1", "terseLabel": "Percentage of total assets", "verboseLabel": "Percentage of concentration risk" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r105", "r106", "r207", "r208" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r77", "r186", "r194", "r195" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation Policy [Text Block]", "terseLabel": "Unaudited Interim Condensed Consolidated Financial Statements" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r160", "r161", "r163" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10130.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract With Customer Liability", "terseLabel": "Deferred revenue" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r55" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost Of Goods And Services Sold", "terseLabel": "Costs Incurred as of June 30, 2020" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r54" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10060.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs And Expenses", "totalLabel": "Total expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Costs And Expenses [Abstract]", "terseLabel": "Expenses" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_CreditConcentrationRiskMember": { "auth_ref": [ "r209" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement.", "label": "Credit Concentration Risk [Member]", "terseLabel": "Credit Concentration Risk [Member]" } } }, "localname": "CreditConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CumulativeEffectOnRetainedEarningsNetOfTax1": { "auth_ref": [ "r88" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of the cumulative effect on retained earnings net of related income tax effect.", "label": "Cumulative Effect On Retained Earnings Net Of Tax1", "terseLabel": "Cumulative effect of change in accounting principles" } } }, "localname": "CumulativeEffectOnRetainedEarningsNetOfTax1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r103" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r7", "r8", "r9", "r243", "r245", "r257" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r9", "r140", "r245", "r257" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail": { "order": 10010.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Debt Instrument Carrying Amount", "terseLabel": "Debt", "totalLabel": "Total" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtPrincipalPaymentsDueForDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r26", "r142", "r217" ], "lang": { "en-US": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument Interest Rate Effective Percentage", "verboseLabel": "Effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r26" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument Interest Rate Stated Percentage", "verboseLabel": "Senior unsecured notes, interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r27", "r203" ], "lang": { "en-US": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.", "label": "Debt Instrument Maturity Date", "terseLabel": "Debt instrument maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r28" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument Name [Domain]", "terseLabel": "Debt Instrument, Name" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r28", "r81", "r148", "r151", "r152", "r153", "r216", "r217", "r219", "r256" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Debt Instrument [Table]", "terseLabel": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r23", "r218" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail": { "order": 10020.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Deferred Finance Costs Net", "negatedLabel": "Debt issue costs and discount, net" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueLeasesCurrent": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred lease income, classified as noncurrent. Includes, but is not limited to, amount paid in advance by lessee.", "label": "Deferred Revenue Leases Current", "terseLabel": "Deferred lease income" } } }, "localname": "DeferredRevenueLeasesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivitiesRentDeferralsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r72", "r132" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10140.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation And Amortization", "terseLabel": "Real estate depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r72", "r110" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10170.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation Depletion And Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock": { "auth_ref": [ "r99", "r230" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of components of lease income from direct financing lease.", "label": "Direct Financing Lease Lease Income Table [Text Block]", "terseLabel": "Components of Total Investment in Financing Leases" } } }, "localname": "DirectFinancingLeaseLeaseIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DirectFinancingLeaseLeaseReceivable": { "auth_ref": [ "r231" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "order": 10030.0, "parentTag": "us-gaap_DirectFinancingLeaseNetInvestmentInLease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term, guaranteed by lessee or other third party unrelated to lessor, from direct financing lease.", "label": "Direct Financing Lease Lease Receivable", "terseLabel": "Minimum lease payments receivable" } } }, "localname": "DirectFinancingLeaseLeaseReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DirectFinancingLeaseNetInvestmentInLease": { "auth_ref": [ "r231" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "order": 10010.0, "parentTag": "us-gaap_NetInvestmentInLease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of net investment in direct financing lease.", "label": "Direct Financing Lease Net Investment In Lease", "totalLabel": "Net investment in direct financing leases" } } }, "localname": "DirectFinancingLeaseNetInvestmentInLease", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DirectFinancingLeaseNetInvestmentInLeasesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Direct Financing Lease Net Investment In Leases [Abstract]", "terseLabel": "Direct Financing Lease Net Investment In Leases [Abstract]" } } }, "localname": "DirectFinancingLeaseNetInvestmentInLeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DirectFinancingLeaseRevenue": { "auth_ref": [ "r99", "r229" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10190.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of direct financing lease revenue.", "label": "Direct Financing Lease Revenue", "terseLabel": "Income from financing leases" } } }, "localname": "DirectFinancingLeaseRevenue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset": { "auth_ref": [ "r231" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "order": 10040.0, "parentTag": "us-gaap_DirectFinancingLeaseNetInvestmentInLease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Present value expected to be derived from underlying asset, following end of lease term, not guaranteed by lessee or other third party unrelated to lessor.", "label": "Direct Financing Lease Unguaranteed Residual Asset", "terseLabel": "Estimated residual values" } } }, "localname": "DirectFinancingLeaseUnguaranteedResidualAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r171" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]", "terseLabel": "Stock Awards" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureStockAwards" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DividendsCommonStockCash": { "auth_ref": [ "r154" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.", "label": "Dividends Common Stock Cash", "negatedLabel": "Dividends (Distributions) declared ($0.25 in 2019 and $0.27 in 2020 per common share/ unit)" } } }, "localname": "DividendsCommonStockCash", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r8", "r10", "r244", "r260" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividends Payable Current And Noncurrent", "terseLabel": "Dividend / Distributions declared, unpaid" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromJointVentures": { "auth_ref": [ "r82", "r233", "r234", "r235", "r270" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "For an unclassified balance sheet, amounts due from an entity in which the reporting entity shares joint control with another party or group.", "label": "Due From Joint Ventures", "terseLabel": "Shareholder loan to joint venture" } } }, "localname": "DueFromJointVentures", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLoansAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r94" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share Basic And Diluted", "terseLabel": "Net income attributable to MPT common stockholders (Operating Partnership partners)" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share Basic And Diluted [Abstract]", "terseLabel": "Earnings per common share (units) basic and diluted" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Earnings Per Share Basic [Line Items]", "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]" } } }, "localname": "EarningsPerShareBasicLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r98" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r210" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents", "terseLabel": "Effect of exchange rate changes" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r147" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r127" ], "lang": { "en-US": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment Ownership Percentage", "terseLabel": "Ownership interest in joint venture under the equity method" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r21", "r114", "r126" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10200.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "auth_ref": [ "r200", "r206" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value By Balance Sheet Grouping [Text Block]", "terseLabel": "Summary of Fair Value Information of Financial Instruments" } } }, "localname": "FairValueByBalanceSheetGroupingTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r200", "r201", "r202", "r203", "r205" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement frequency.", "label": "Fair Value By Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r204" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement frequency.", "label": "Fair Value Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r204", "r205" ], "lang": { "en-US": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value Measurements Recurring [Member]", "terseLabel": "Fair Value Measurements, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of difference between the carrying amount and the sales price of real estate properties sold as part of discontinued operations.", "label": "Gain Loss On Disposition Of Real Estate Discontinued Operations", "terseLabel": "Net loss on real estate dispositions" } } }, "localname": "GainLossOnDispositionOfRealEstateDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDisposalsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnSalesOfInvestmentRealEstate": { "auth_ref": [ "r52", "r53", "r72", "r252", "r273", "r275", "r276", "r277" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10210.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10080.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.", "label": "Gains Losses On Sales Of Investment Real Estate", "negatedLabel": "Loss from sale of real estate and other", "terseLabel": "Loss on sale of real estate" } } }, "localname": "GainsLossesOnSalesOfInvestmentRealEstate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r56" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10160.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General And Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralPartnerMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Party to a partnership business who has unlimited liability.", "label": "General Partner [Member]", "terseLabel": "General Partner [Member]" } } }, "localname": "GeneralPartnerMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralPartnersCapitalAccount": { "auth_ref": [ "r156" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets2": { "order": 10010.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of the general partner's ownership interest.", "label": "General Partners Capital Account", "terseLabel": "General Partner \u2014 issued and outstanding \u2014 [ ] units at June 30, 2020and 5,176 units at December 31, 2019" } } }, "localname": "GeneralPartnersCapitalAccount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralPartnersCapitalAccountUnitsIssued": { "auth_ref": [ "r156" ], "lang": { "en-US": { "role": { "documentation": "The number of general partner units issued.", "label": "General Partners Capital Account Units Issued", "terseLabel": "General partner, units issued" } } }, "localname": "GeneralPartnersCapitalAccountUnitsIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_GeneralPartnersCapitalAccountUnitsOutstanding": { "auth_ref": [ "r156" ], "lang": { "en-US": { "role": { "documentation": "The number of general partner units outstanding.", "label": "General Partners Capital Account Units Outstanding", "terseLabel": "General partner, units outstanding" } } }, "localname": "GeneralPartnersCapitalAccountUnitsOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r104" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic Concentration [Member]" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfRealEstate": { "auth_ref": [ "r72", "r135" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The charge against earnings in the period to reduce the carrying amount of real property to fair value.", "label": "Impairment Of Real Estate", "terseLabel": "Real estate impairment charge" } } }, "localname": "ImpairmentOfRealEstate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r49", "r87", "r239", "r253", "r274" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10030.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest", "totalLabel": "Income before income tax" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r50", "r72", "r111", "r126", "r251", "r271" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10100.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income Loss From Equity Method Investments", "terseLabel": "Earnings from equity interests" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r78", "r112", "r172" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10040.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense Benefit", "negatedLabel": "Income tax (expense) benefit" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r71" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10280.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase Decrease In Accounts Payable And Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase Decrease In Operating Capital [Abstract]", "terseLabel": "Changes in:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r92", "r96" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail": { "order": 10020.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable To Share Based Payment Arrangements", "terseLabel": "Dilutive potential common shares" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_InterestAndOtherIncome": { "auth_ref": [], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10200.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).", "label": "Interest And Other Income", "terseLabel": "Interest and other income" } } }, "localname": "InterestAndOtherIncome", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r47", "r109", "r215", "r218", "r255" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10130.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r75" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest Paid", "terseLabel": "Interest paid" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedAtCost": { "auth_ref": [ "r281" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Cost of the investment.", "label": "Investment Owned At Cost", "terseLabel": "Book value" } } }, "localname": "InvestmentOwnedAtCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedAtFairValue": { "auth_ref": [ "r281", "r284", "r286", "r288", "r289" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.", "label": "Investment Owned At Fair Value", "terseLabel": "Fair value" } } }, "localname": "InvestmentOwnedAtFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r283", "r285", "r287", "r290" ], "lang": { "en-US": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r283", "r285", "r287", "r290" ], "lang": { "en-US": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investment Type Categorization [Member]", "terseLabel": "Investments" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r200" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments Fair Value Disclosure", "terseLabel": "Total investments" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandAndLandImprovementsMember": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Real estate held and assets that are an addition or improvement to real estate held.", "label": "Land And Land Improvements [Member]", "terseLabel": "Land and Land Improvements [Member]" } } }, "localname": "LandAndLandImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend": { "auth_ref": [ "r221" ], "lang": { "en-US": { "role": { "documentation": "Indicates (true false) whether lessee has option to extend operating lease.", "label": "Lessee Operating Lease Existence Of Option To Extend", "terseLabel": "Existence of option to extend" } } }, "localname": "LesseeOperatingLeaseExistenceOfOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "booleanItemType" }, "us-gaap_LesseeOperatingLeaseOptionToExtend": { "auth_ref": [ "r221" ], "lang": { "en-US": { "role": { "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.", "label": "Lessee Operating Lease Option To Extend", "terseLabel": "Lease extension options, description" } } }, "localname": "LesseeOperatingLeaseOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LessorLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessor Lease Description [Line Items]", "terseLabel": "Lessor Lease Description [Line Items]" } } }, "localname": "LessorLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LessorLeaseDescriptionTable": { "auth_ref": [ "r228" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about lessor's leases.", "label": "Lessor Lease Description [Table]", "terseLabel": "Lessor Lease Description [Table]" } } }, "localname": "LessorLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LessorOperatingLeaseExistenceOfOptionToExtend": { "auth_ref": [ "r227" ], "lang": { "en-US": { "role": { "documentation": "Indicates (true false) whether lessor has option to extend operating lease.", "label": "Lessor Operating Lease Existence Of Option To Extend", "terseLabel": "Existence of option to extend" } } }, "localname": "LessorOperatingLeaseExistenceOfOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "booleanItemType" }, "us-gaap_LessorOperatingLeaseOptionToExtend": { "auth_ref": [ "r227" ], "lang": { "en-US": { "role": { "documentation": "Description of terms and conditions of option to extend lessor's operating lease.", "label": "Lessor Operating Lease Option To Extend", "terseLabel": "Lease extension options, description" } } }, "localname": "LessorOperatingLeaseOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LessorOperatingLeaseRenewalTerm": { "auth_ref": [ "r227" ], "lang": { "en-US": { "role": { "documentation": "Term of lessor's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor Operating Lease Renewal Term", "terseLabel": "Lease renewal term", "verboseLabel": "Term of lease extension, years" } } }, "localname": "LessorOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_LessorOperatingLeaseTermOfContract": { "auth_ref": [ "r227" ], "lang": { "en-US": { "role": { "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor Operating Lease Term Of Contract", "terseLabel": "Term of lease" } } }, "localname": "LessorOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r25" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10010.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r18", "r247", "r265" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities And Stockholders Equity", "totalLabel": "Total Liabilities and Equity / Capital" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities And Stockholders Equity [Abstract]", "terseLabel": "Liabilities and Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest": { "auth_ref": [ "r102" ], "lang": { "en-US": { "role": { "documentation": "Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP).", "label": "Limited Liability Company L L C Or Limited Partnership L P Members Or Limited Partners Ownership Interest", "verboseLabel": "Percentage of ownership limited partner" } } }, "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_LimitedPartnerMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Party to a partnership business who has limited liability.", "label": "Limited Partner [Member]", "terseLabel": "Limited Partner [Member]" } } }, "localname": "LimitedPartnerMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_LimitedPartnersCapitalAccount": { "auth_ref": [ "r101", "r156" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets2": { "order": 10020.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of the limited partners' ownership interests.", "label": "Limited Partners Capital Account", "terseLabel": "Common units \u2014 issued and outstanding \u2014 523,354 units at June 30, 2020 and 512,346 units at December 31, 2019" } } }, "localname": "LimitedPartnersCapitalAccount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LimitedPartnersCapitalAccountAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Limited Partners Capital Account [Abstract]", "terseLabel": "Limited Partners:" } } }, "localname": "LimitedPartnersCapitalAccountAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LimitedPartnersCapitalAccountUnitsIssued": { "auth_ref": [ "r101", "r156" ], "lang": { "en-US": { "role": { "documentation": "The number of limited partner units issued.", "label": "Limited Partners Capital Account Units Issued", "terseLabel": "LTIP Units, shares issued" } } }, "localname": "LimitedPartnersCapitalAccountUnitsIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding": { "auth_ref": [ "r101", "r156" ], "lang": { "en-US": { "role": { "documentation": "The number of limited partner units outstanding.", "label": "Limited Partners Capital Account Units Outstanding", "terseLabel": "LTIP Units, shares outstanding" } } }, "localname": "LimitedPartnersCapitalAccountUnitsOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r24" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line Of Credit Facility Maximum Borrowing Capacity", "verboseLabel": "Maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansAndLeasesReceivableAllowance": { "auth_ref": [ "r121", "r122", "r124", "r125", "r250" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance to cover probable credit losses on loans and leases. Includes carryover of or adjustments to the allowance for loan losses in connection with business combinations. Excludes allowance for loans and leases covered under loss sharing agreements.", "label": "Loans And Leases Receivable Allowance", "terseLabel": "Credit loss reserve expected" } } }, "localname": "LoansAndLeasesReceivableAllowance", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansHeldForSaleFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of loans held-for-sale including, but not limited to, mortgage loans and finance receivables.", "label": "Loans Held For Sale Fair Value Disclosure", "terseLabel": "Loans, Fair value" } } }, "localname": "LoansHeldForSaleFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r9", "r141", "r245", "r261" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10110.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long Term Debt", "negatedLabel": "Debt, net Book value", "terseLabel": "Debt, net", "totalLabel": "Debt, net" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long Term Debt Fair Value", "negatedLabel": "Debt, net Fair value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r84", "r139" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "order": 10020.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long Term Debt Maturities Repayments Of Principal In Next Twelve Months", "terseLabel": "2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r84", "r139" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "order": 10050.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long Term Debt Maturities Repayments Of Principal In Year Four", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r84", "r139" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "order": 10040.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long Term Debt Maturities Repayments Of Principal In Year Three", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r84", "r139" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "order": 10030.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long Term Debt Maturities Repayments Of Principal In Year Two", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r84" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtPrincipalPaymentsDueForDebtDetail": { "order": 10010.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year", "terseLabel": "2020" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r143" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "Long Term Debt [Text Block]", "terseLabel": "Debt" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_MajorPropertyClassAxis": { "auth_ref": [ "r220" ], "lang": { "en-US": { "role": { "documentation": "Amount of property owned but leased or available for lease to third parties, by major property class.", "label": "Major Property Class [Axis]", "terseLabel": "Major Property Class" } } }, "localname": "MajorPropertyClassAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_MajorPropertyClassDomain": { "auth_ref": [ "r220" ], "lang": { "en-US": { "role": { "documentation": "The major classes of assets leased or available for lease to third parties under operating lease agreements as of the balance sheet date.", "label": "Major Property Class [Domain]", "terseLabel": "Major Property Class" } } }, "localname": "MajorPropertyClassDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r33", "r246", "r264" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10040.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Minority Interest", "terseLabel": "Non-controlling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "auth_ref": [ "r154" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Minority Interest Decrease From Distributions To Noncontrolling Interest Holders", "negatedLabel": "Distributions to non-controlling interests" } } }, "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet": { "auth_ref": [ "r267" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10270.0, "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio.", "label": "Mortgage Loans On Real Estate Commercial And Consumer Net", "terseLabel": "Mortgage loans" } } }, "localname": "MortgageLoansOnRealEstateCommercialAndConsumerNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MortgagesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan.", "label": "Mortgages [Member]", "terseLabel": "Mortgage Loans [Member]" } } }, "localname": "MortgagesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r69" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10030.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided By Used In Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided By Used In Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r69" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10020.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided By Used In Investing Activities", "totalLabel": "Net cash used for investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided By Used In Investing Activities [Abstract]", "terseLabel": "Investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r69", "r70", "r73" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10010.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided By Used In Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r42", "r44", "r51", "r73", "r96", "r254", "r272" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income Loss", "totalLabel": "Net income attributable to MPT common stockholders (Operating Partnership partners)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r42", "r44", "r188", "r192" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail": { "order": 10040.0, "parentTag": "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings", "weight": -1.0 }, "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10020.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income Loss Attributable To Noncontrolling Interest", "negatedLabel": "Net income attributable to non-controlling interests", "negatedTerseLabel": "Non-controlling interests\u2019 share in net income" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentInLease": { "auth_ref": [ "r224" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10260.0, "parentTag": "mpw_GrossInvestmentInRealEstateAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of net investment in sales-type and direct financing lease.", "label": "Net Investment In Lease", "terseLabel": "Investment in financing leases", "totalLabel": "Total investment in financing leases" } } }, "localname": "NetInvestmentInLease", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r181" ], "lang": { "en-US": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-Controlling Interests [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r57" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10070.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income Expense", "totalLabel": "Total other income (expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Nonoperating Income Expense [Abstract]", "terseLabel": "Other income (expense)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NotesReceivableGross": { "auth_ref": [ "r129" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfLoansNetOfAllowanceForCreditLossDetail": { "order": 10010.0, "parentTag": "us-gaap_NotesReceivableNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allowance for credit loss, of financing receivable.", "label": "Notes Receivable Gross", "terseLabel": "Mortgage loans" } } }, "localname": "NotesReceivableGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfLoansNetOfAllowanceForCreditLossDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReceivableNet": { "auth_ref": [ "r13", "r120", "r129" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfLoansNetOfAllowanceForCreditLossDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.", "label": "Notes Receivable Net", "totalLabel": "Total" } } }, "localname": "NotesReceivableNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfLoansNetOfAllowanceForCreditLossDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfBusinessesAcquired": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The number of businesses acquired by the entity during the period.", "label": "Number Of Businesses Acquired", "terseLabel": "Number of facilities acquired" } } }, "localname": "NumberOfBusinessesAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The number of countries in which the entity operates as of balance sheet date.", "label": "Number Of Countries In Which Entity Operates", "terseLabel": "Number of countries" } } }, "localname": "NumberOfCountriesInWhichEntityOperates", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureOrganizationAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfStatesInWhichEntityOperates": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The number of states the entity operates in as of the balance sheet date.", "label": "Number Of States In Which Entity Operates", "terseLabel": "Number of states" } } }, "localname": "NumberOfStatesInWhichEntityOperates", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureOrganizationAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r222", "r223" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease Weighted Average Remaining Lease Term1", "terseLabel": "Weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r196" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureOrganization" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r6", "r241", "r258" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10220.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other Assets", "terseLabel": "Other assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r197", "r199" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other Assets [Member]" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r36", "r38", "r211", "r212", "r213", "r214" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 10050.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax", "terseLabel": "Foreign currency translation gain (loss)", "verboseLabel": "Foreign currency translation gain (loss)" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract]", "terseLabel": "Other comprehensive income:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r73" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10260.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income Expense", "negatedLabel": "Other adjustments" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r58" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10120.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income Expense", "terseLabel": "Other (including mark-to-market adjustments on equity securities)" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PartnerTypeOfPartnersCapitalAccountAxis": { "auth_ref": [ "r100", "r155" ], "lang": { "en-US": { "role": { "documentation": "Information by type or class of partner's capital account. Examples of classes of partners include, but not limited to, general partners, limited partners, preferred partners, and other ownership interests.", "label": "Partner Type Of Partners Capital Account [Axis]", "terseLabel": "Partner Type" } } }, "localname": "PartnerTypeOfPartnersCapitalAccountAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain": { "auth_ref": [ "r100", "r156", "r282" ], "lang": { "en-US": { "role": { "documentation": "Capital accounts of each type or class of partner. Examples of classes of partners include, but are not limited to, general partners, limited partners, preferred partners, and other ownership interests.", "label": "Partner Type Of Partners Capital Account Name [Domain]", "terseLabel": "Partner Type of Partners' Capital Account, Name" } } }, "localname": "PartnerTypeOfPartnersCapitalAccountNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_PartnersCapitalAccountUnitsSaleOfUnits": { "auth_ref": [ "r102", "r154" ], "lang": { "en-US": { "role": { "documentation": "Total units issued during the year due to the sale of units. All partners include general, limited and preferred partners.", "label": "Partners Capital Account Units Sale Of Units", "terseLabel": "Number of units sold" } } }, "localname": "PartnersCapitalAccountUnitsSaleOfUnits", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PartnersCapitalNotesDisclosureTextBlock": { "auth_ref": [ "r159" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the formation, structure, control and ownership of the partnership. Disclosures related to accounts comprising partners' capital. Includes balances of general partners' capital account, limited partners' capital account, preferred partners' capital account and total partners' capital account and units outstanding; accumulated other comprehensive income; amount and nature of changes to amount of partner's capital and units outstanding by class, rights and privileges for each class of units; distribution policies and distributions paid by unit class; impact of and correction of an error in previously issued financial statements; limitations of partners' liability; redemption, conversion and distribution policies; and deferred compensation related to the issuance of units.", "label": "Partners Capital Notes Disclosure [Text Block]", "terseLabel": "Common Stock/Partner's Capital" } } }, "localname": "PartnersCapitalNotesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnerSCapital" ], "xbrltype": "textBlockItemType" }, "us-gaap_PaymentsOfOrdinaryDividends": { "auth_ref": [ "r66" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10060.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.", "label": "Payments Of Ordinary Dividends", "negatedLabel": "Dividends / Distribution paid" } } }, "localname": "PaymentsOfOrdinaryDividends", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireLoansReceivable": { "auth_ref": [ "r61" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10140.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for the purchase of loan receivable arising from the financing of goods and services.", "label": "Payments To Acquire Loans Receivable", "negatedLabel": "Investment in loans receivable" } } }, "localname": "PaymentsToAcquireLoansReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireRealEstate": { "auth_ref": [ "r62" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10110.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner.", "label": "Payments To Acquire Real Estate", "negatedLabel": "Cash paid for acquisitions and other related investments" } } }, "localname": "PaymentsToAcquireRealEstate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Par Value [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock Par Or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r11" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10050.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock Value", "terseLabel": "Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.", "label": "Prior Period Reclassification Adjustment Description", "terseLabel": "Reclassifications" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromCollectionOfLoansReceivable": { "auth_ref": [ "r59" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10130.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services.", "label": "Proceeds From Collection Of Loans Receivable", "terseLabel": "Principal received on loans receivable" } } }, "localname": "ProceedsFromCollectionOfLoansReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonLimitedPartnersUnits": { "auth_ref": [ "r63" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10080.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the issuance of common limited partners units during the period.", "label": "Proceeds From Issuance Of Common Limited Partners Units", "terseLabel": "Proceeds from sale of units, net of offering costs" } } }, "localname": "ProceedsFromIssuanceOfCommonLimitedPartnersUnits", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r63" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10090.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds From Issuance Of Common Stock", "terseLabel": "Proceeds from sale of common shares, net of offering costs", "verboseLabel": "Proceeds from sale of common shares / units, net of offering costs" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r64" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10040.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds From Issuance Of Long Term Debt", "terseLabel": "Proceeds from term debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLeasePayments": { "auth_ref": [ "r225", "r226" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflows from lease payments.", "label": "Proceeds From Lease Payments", "terseLabel": "Proceeds from lease payments" } } }, "localname": "ProceedsFromLeasePayments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r65", "r67", "r83" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10100.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds From Payments For Other Financing Activities", "terseLabel": "Payment of deferred financing costs and other financing activities" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "auth_ref": [ "r83" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10050.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).", "label": "Proceeds From Repayments Of Lines Of Credit", "terseLabel": "Revolving credit facilities, net" } } }, "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "auth_ref": [ "r60" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10120.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Proceeds From Sale Of Productive Assets", "terseLabel": "Net proceeds from sale of real estate" } } }, "localname": "ProceedsFromSaleOfProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfRealEstate": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Cash received for the sale of real estate that is not part of an investing activity during the current period.", "label": "Proceeds From Sale Of Real Estate", "terseLabel": "Proceeds from sale of facilities" } } }, "localname": "ProceedsFromSaleOfRealEstate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDisposalsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r42", "r44", "r68", "r113", "r116", "r183", "r187", "r189", "r192", "r193" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail": { "order": 10030.0, "parentTag": "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings", "weight": 1.0 }, "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10160.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 10030.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10010.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Profit Loss", "terseLabel": "Net income", "totalLabel": "Net income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r22", "r134" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property Plant And Equipment By Type [Axis]", "terseLabel": "Property, Plant and Equipment, Type" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredParentheticalDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r5", "r133" ], "lang": { "en-US": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property Plant And Equipment Type [Domain]", "terseLabel": "Property, Plant and Equipment, Type" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredParentheticalDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RealEstateAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Real Estate [Abstract]" } } }, "localname": "RealEstateAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RealEstateDisclosureTextBlock": { "auth_ref": [ "r295", "r296", "r297", "r298", "r299" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for certain real estate investment financial statements, real estate investment trust operating support agreements, real estate owned, retail land sales, time share transactions, as well as other real estate related disclosures.", "label": "Real Estate Disclosure [Text Block]", "terseLabel": "Real Estate and Lending Activities" } } }, "localname": "RealEstateDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_RealEstateInvestmentPropertyNet": { "auth_ref": [ "r268" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.", "label": "Real Estate Investment Property Net", "positiveLabel": "Net investment in lease" } } }, "localname": "RealEstateInvestmentPropertyNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstatePropertiesAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by ownership of the property.", "label": "Real Estate Properties [Axis]", "terseLabel": "Real Estate Property Ownership" } } }, "localname": "RealEstatePropertiesAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RealEstatePropertiesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents categories of ownership of real estate properties.", "label": "Real Estate Properties [Domain]", "terseLabel": "Real Estate Properties" } } }, "localname": "RealEstatePropertiesDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesFairValueDisclosure": { "auth_ref": [ "r19", "r34", "r248", "r266" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of receivables, including, but not limited to, trade account receivables, note receivables, and loan receivables.", "label": "Receivables Fair Value Disclosure", "terseLabel": "Interest and rent receivables, Fair value" } } }, "localname": "ReceivablesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResidualValueOfLeasedAsset": { "auth_ref": [ "r232" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of residual asset covered by residual value guarantee. Excludes guarantee considered to be lease payments for lessor.", "label": "Residual Value Of Leased Asset", "terseLabel": "Carrying value of lease requiring residual value guarantee" } } }, "localname": "ResidualValueOfLeasedAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r4", "r74", "r76", "r240", "r262" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash And Cash Equivalents", "periodEndLabel": "Restricted cash, included in Other assets at end of period", "periodStartLabel": "Restricted cash, included in Other assets at beginning of period" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r76" ], "lang": { "en-US": { "role": { "documentation": "Indicates line item in statement of financial position that includes cash and cash equivalents restricted to withdrawal or usage.", "label": "Restricted Cash And Cash Equivalents Asset Statement Of Financial Position Extensible List", "periodEndLabel": "Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]", "periodStartLabel": "Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]" } } }, "localname": "RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "extensibleListItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r15", "r154", "r263" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10080.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings Accumulated Deficit", "terseLabel": "Retained (deficit) earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings (Deficit) [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r48", "r107", "r108", "r115" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited": { "order": 10050.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "totalLabel": "Total revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtSummaryOfDebtDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r105" ], "lang": { "en-US": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Sales Revenue Net [Member]", "terseLabel": "Revenue [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r174", "r175" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule Of Business Acquisitions By Acquisition [Table]", "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2019ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivitiesRentDeferralsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAdeptusHealthTransitionPropertiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesAlectoFacilitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesConcentrationOfCreditRisksAndRelatedPartyTransactionsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesNetAssetsAcquiredParentheticalDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r174", "r175" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule Of Business Acquisitions By Acquisition [Text Block]", "terseLabel": "Net Assets Acquired" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateAndLendingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule Of Debt Table [Text Block]", "terseLabel": "Summary of Debt" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r96" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]", "terseLabel": "Calculation of Earnings Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": { "auth_ref": [ "r91", "r93", "r95", "r97" ], "lang": { "en-US": { "role": { "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.", "label": "Schedule Of Earnings Per Share Basic By Common Class [Table]", "terseLabel": "Schedule Of Earnings Per Share Basic By Common Class [Table]" } } }, "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r167", "r170" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r30", "r80", "r144", "r145", "r146", "r148", "r149", "r150", "r151", "r152", "r153", "r154" ], "lang": { "en-US": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule Of Stock By Class [Table]", "terseLabel": "Schedule Of Stock By Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SecuredDebt": { "auth_ref": [ "r9", "r245", "r261" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Secured Debt", "terseLabel": "Secured loan" } } }, "localname": "SecuredDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivities2020ActivityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r71" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10200.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share Based Compensation", "terseLabel": "Share / (Unit)-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureStockAwardsAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r168" ], "lang": { "en-US": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized", "terseLabel": "Reserved shares of common stock for awards under the Equity Incentive Plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r170" ], "lang": { "en-US": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant", "terseLabel": "Common stock remaining for future stock awards transferred to the equity incentive plan" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r166", "r169" ], "lang": { "en-US": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]", "terseLabel": "Award Type" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureStockAwardsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r85" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r32", "r147" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components [Axis]", "terseLabel": "Equity Components" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement Of Income And Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement Of Stockholders Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r11", "r12", "r147", "r154" ], "lang": { "en-US": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period Shares New Issues", "terseLabel": "Proceeds from offering (net of offering costs) (shares)", "verboseLabel": "Number of share sold" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureCommonStockPartnersCapitalAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r11", "r12", "r147", "r154" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period Value New Issues", "terseLabel": "Proceeds from offering (net of offering costs)" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r12", "r16", "r17", "r123" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10030.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders Equity", "totalLabel": "Total Medical Properties Trust, Inc. Stockholders' Equity (MPT Operating Partnership, L.P. capital)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r181", "r182", "r191" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10020.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders Equity Including Portion Attributable To Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total Equity / Capital" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders Equity Including Portion Attributable To Noncontrolling Interest [Abstract]", "terseLabel": "Equity / Capital" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r236" ], "lang": { "en-US": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r236" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r236" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r238" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r31", "r157" ], "lang": { "en-US": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Shares [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfEquityCapital" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r31", "r157", "r158" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10100.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock Value", "negatedLabel": "Treasury shares, at cost" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.", "label": "Type Of Adoption [Member]", "terseLabel": "Type of Adoption" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_UnusualRiskOrUncertaintyByNatureAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by nature of risk and uncertainty, for example, but not limited to, threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.", "label": "Unusual Risk Or Uncertainty By Nature [Axis]", "terseLabel": "Unusual Risk or Uncertainty, Nature" } } }, "localname": "UnusualRiskOrUncertaintyByNatureAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivitiesRentDeferralsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualRiskOrUncertaintyNatureDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Describes the nature of the unusual risk or uncertainty, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost.", "label": "Unusual Risk Or Uncertainty Nature [Domain]", "terseLabel": "Unusual Risk or Uncertainty, Nature" } } }, "localname": "UnusualRiskOrUncertaintyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureRealEstateActivitiesAndLendingActivitiesRentDeferralsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtAustralianTermLoanFacilityAdditionalInformationDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureDebtBritishPoundSterlingTermLoanAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r90", "r95" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number Of Diluted Shares Outstanding", "terseLabel": "Weighted average shares (units) outstanding diluted", "totalLabel": "Dilutive weighted-average common shares" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r89", "r95" ], "calculation": { "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail": { "order": 10010.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number Of Shares Outstanding Basic", "terseLabel": "Weighted average shares (units) outstanding basic", "verboseLabel": "Basic weighted-average common shares" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/DisclosureEarningsPerShareCalculationOfEarningsPerShareDetail", "http://www.medicalpropertiestrust.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "xbrltype": "sharesItemType" } }, "unitCount": 17 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9054-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4647-111522" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=SL6953423-111524" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=SL6953423-111524" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.L.1)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)(ii)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118939070&loc=d3e15032-111544" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118950378&loc=SL82887624-210437" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919230-210447" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r136": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349" }, "r138": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870" }, "r143": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.F)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187171-122770" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.F)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187171-122770" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r159": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r171": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868840&loc=d3e2207-128464" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-02)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-03)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828" }, "r196": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13467-108611" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32157-110900" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=84164653&loc=d3e41551-112718" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888421&loc=SL77919306-209978" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888421&loc=SL77919320-209978" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888421&loc=SL77919327-209978" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919359-209981" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919359-209981" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919372-209981" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919372-209981" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919379-209981" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919381-209981" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r238": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(1),(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.7(d))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(14)(d))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(c))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(d))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "360", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117337397&loc=d3e23415-158514" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "360", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117337397&loc=d3e23439-158514" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117337411&loc=d3e23528-158515" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=6488278&loc=d3e603758-122996" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(2)(i))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611133-123010" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12.Column C.3,4)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611133-123010" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12C(1)(a))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611225-123010" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12C.Column C.7)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611225-123010" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611282-123010" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13.Column C.6)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611282-123010" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14.Column E.2,3)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611322-123010" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611379-123010" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28)", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r295": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "970", "URI": "http://asc.fasb.org/topic&trid=2156125" }, "r296": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "972", "URI": "http://asc.fasb.org/topic&trid=2134617" }, "r297": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "974", "URI": "http://asc.fasb.org/topic&trid=2156429" }, "r298": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "976", "URI": "http://asc.fasb.org/topic&trid=2134846" }, "r299": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "978", "URI": "http://asc.fasb.org/topic&trid=2134977" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r300": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r301": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r302": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" }, "r303": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r304": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r305": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "303", "Subparagraph": "(5)" }, "r306": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r307": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r308": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r309": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r310": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r311": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08" }, "r312": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "c", "Publisher": "SEC", "Section": "5", "Subparagraph": "Schedule III", "Subsection": "04" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13728-122682" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(d),(e))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04.(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690" }, "r85": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1500-109256" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1278-109256" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258" }, "r98": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=118952077&loc=SL77927221-108306" } }, "version": "2.1" }